Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125662271 | 12566227 | 1 | I | 20160706 | 20160718 | 20160718 | EXP | CA-HQ SPECIALTY-CA-2016INT000561 | INTERCHEM | 52.00 | YR | F | Y | 0.00000 | 20160718 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125662271 | 12566227 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 25 MG, UNK | N | 201749 | 25 | MG | |||||||
| 125662271 | 12566227 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125662271 | 12566227 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | 40 MG, UNK | N | 0 | 40 | MG | |||||||
| 125662271 | 12566227 | 4 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, UNK | N | 0 | 20 | MG | |||||||
| 125662271 | 12566227 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | 4 MG/KG, UNK | U | 0 | 4 | MG/KG | |||||||
| 125662271 | 12566227 | 6 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | UNK | U | 0 | |||||||||
| 125662271 | 12566227 | 7 | SS | NAPROSYN | NAPROXEN | 1 | Unknown | 500 MG, UNK | U | 0 | 500 | MG | |||||||
| 125662271 | 12566227 | 8 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | N | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125662271 | 12566227 | 1 | Rheumatoid arthritis |
| 125662271 | 12566227 | 2 | Arthralgia |
| 125662271 | 12566227 | 3 | Rheumatoid arthritis |
| 125662271 | 12566227 | 4 | Rheumatoid arthritis |
| 125662271 | 12566227 | 5 | Product used for unknown indication |
| 125662271 | 12566227 | 6 | Rheumatoid arthritis |
| 125662271 | 12566227 | 7 | Product used for unknown indication |
| 125662271 | 12566227 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125662271 | 12566227 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125662271 | 12566227 | Blood alkaline phosphatase increased | |
| 125662271 | 12566227 | Drug ineffective | |
| 125662271 | 12566227 | Pneumonia | |
| 125662271 | 12566227 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125662271 | 12566227 | 1 | 200910 | 201205 | 0 | |
| 125662271 | 12566227 | 3 | 201001 | 201008 | 0 | |
| 125662271 | 12566227 | 4 | 200910 | 201302 | 0 | |
| 125662271 | 12566227 | 5 | 201301 | 201310 | 0 |